291 related articles for article (PubMed ID: 9100597)
1. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
7. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
Wilson ME
J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
Wilson ME
J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
[TBL] [Abstract][Full Text] [Related]
9. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
[TBL] [Abstract][Full Text] [Related]
10. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
[TBL] [Abstract][Full Text] [Related]
11. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury.
Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN
J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411
[TBL] [Abstract][Full Text] [Related]
12. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
13. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
14. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys.
LeRoith D; Yanowski J; Kaldjian EP; Jaffe ES; LeRoith T; Purdue K; Cooper BD; Pyle R; Adler W
Endocrinology; 1996 Mar; 137(3):1071-9. PubMed ID: 8603576
[TBL] [Abstract][Full Text] [Related]
15. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
Bauss F; Lang K; Dony C; Kling L
Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
[TBL] [Abstract][Full Text] [Related]
16. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
[TBL] [Abstract][Full Text] [Related]
17. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
Liang LJ; Luo SM; Hu WJ
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I.
Ward WE; Donovan SM; Atkinson SA
Pediatr Res; 1998 Aug; 44(2):215-21. PubMed ID: 9702917
[TBL] [Abstract][Full Text] [Related]
20. Administration of IGF-I affects the GH axis and adolescent growth in normal monkeys.
Wilson ME
J Endocrinol; 1997 May; 153(2):327-35. PubMed ID: 9166124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
